دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment
Filippo Crea
doi : 10.1093/eurheartj/ehab576
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3109–3113
The need for ethical and pragmatic strategies for sample and data collection during public health emergencies—minimizing missed opportunities
Rafael Escandon, Bettina Heidecker
doi : 10.1093/eurheartj/ehab102
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3114–3116
A glimpse into the future of cardiology: how can advanced technologies lead to compassionate care?
Bertalan Mesko
doi : 10.1093/eurheartj/ehab167
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3114–3116
Jeffrey B. Geske, MD
Jeffrey B Geske, MD
doi : 10.1093/eurheartj/ehab142
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Page 3119
Paul A. Friedman has been appointed as a new Board Reviewer of the European Heart Journal
doi : 10.1093/eurheartj/ehab216
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3119–3120
Worsening of risk factor control in US diabetic patients: a call to action
Massimo Volpe, Carlo Patrono
doi : 10.1093/eurheartj/ehab501
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3120–3121
Clinician Well-Being—addressing global needs for improvements in the health care field: a joint opinion from the American College of Cardiology, American Heart Association, European Society of Cardiology, World Heart Federation
Laxmi S Mehta, Mitchell S V Elkind, Stephan Achenbach, Fausto J Pinto, Athena Poppas
doi : 10.1093/eurheartj/ehab346
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3122–3126
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome
?scar Mir?, S?nia Jiménez, Alexandre Mebazaa, Yonathan Freund, Guillermo Burillo-Putze, Alfonso Mart?n, Francisco Javier Mart?n-S?nchez, Eric Jorge Garc?a-Lamberechts, Aitor Alquézar-Arbé, Javier Jacob, Pere Llorens, Pascual Pi?era, V?ctor Gil, Josep Guardiola, Carlos Cardozo, Josep Maria M?dol Deltell, Josep Tost, Alfons Aguirre Tejedo, Anna Palau-Vendrell, Llu?s LLauger Garc?a, Maria Adroher Mu?oz, Carmen del Arco Gal?n, Teresa Agudo Villa, Nieves L?pez-Laguna, Mar?a Pilar L?pez D?ez, Fahd Beddar Chaib, Eva Quero Motto, Matilde Gonz?lez Tejera, Mar?a Carmen Ponce, Juan Gonz?lez del Castillo, the Spanish Investigators on Emergency Situations TeAm (SIESTA) network
doi : 10.1093/eurheartj/ehab314
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3127–3142
We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization.
Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality?
Noel Chan, John Eikelboom
doi : 10.1093/eurheartj/ehab417
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3143–3145
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
Pierre-Marie Roy, Andrea Penaloza, Olivier Hugli, Frederikus A Klok, Armelle Arnoux, Antoine Elias, Francis Couturaud, Luc-Marie Joly, Raphaëlle Lopez, Laura M Faber, Marie Daoud-Elias, Benjamin Planquette, Jérôme Bokobza, Damien Viglino, Jeannot Schmidt, Henry Juchet, Isabelle Mahe, Frits Mulder, Magali Bartiaux, Rosen Cren, Thomas Moumneh, Isabelle Quere, Nicolas Falvo, Karine Montaclair, Delphine Douillet, Charlotte Steinier, Stephan V Hendriks, Ygal Benhamou, Tali-Anne Szwebel, Gilles Pernod, Nicolas Dublanchet, François-Xavier Lapebie, Nicolas Javaud, Alexandre Ghuysen, Mustapha Sebbane, Gilles Chatellier, Guy Meyer, David Jimenez, Menno V Huisman, Olivier Sanchez, for the HOME-PE Study Group
doi : 10.1093/eurheartj/ehab373
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3146–3157
The aim of this study is to compare the Hestia rule vs. the simplified Pulmonary Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism (PE) for home treatment.
Home management or hospital admission for low-risk pulmonary embolism? Clinical scores versus pragmatic assessment
Cecilia Becattini, Ludovica Anna Cimini, Giancarlo Agnelli
doi : 10.1093/eurheartj/ehab491
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3158–3160
Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry
Enrico Cerrato, Federico Giacobbe, Giorgio Quadri, Fernando Macaya, Matteo Bianco, Ricardo Mori, Carlo Alberto Biolè, Alberto Boi, Luca Bettari, Cristina Rolfo, Fabio Ferrari, Gianmarco Annibali, Massimiliano Scappaticci, Marco Pavani, Umberto Barbero, Dario Buccheri, Chiara Cavallino, Primiano Lombardi, Chiara Bernelli, Fabrizio D’Ascenzo, Vincenzo Infantino, Alfonso Gambino, Sebastian Cinconze, Andrea Rognoni, Laura Montagna, Italo Porto, Giuseppe Musumeci, Javier Escaned, Ferdinando Varbella, DISCO Collaborators
doi : 10.1093/eurheartj/ehab372
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3161–3171
The role of antiplatelet therapy in patients with spontaneous coronary artery dissection (SCAD) undergoing initial conservative management is still a matter of debate, with theoretical arguments in favour and against its use. The aims of this article are to assess the use of antiplatelet drugs in medically treated SCAD patients and to investigate the relationship between single (SAPT) and dual (DAPT) antiplatelet regimens and 1-year patient outcomes.
First, do no harm
Sharonne N Hayes
doi : 10.1093/eurheartj/ehab442
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3172–3174
LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project
Qing Yang, Dongdong Sun, Chongzhe Pei, Yuhong Zeng, Zhuoqun Wang, Ziping Li, Yongchen Hao, Xiwen Song, Yongle Li, Gang Liu, Yida Tang, Sidney C Smith, Jr, Yaling Han, Yong Huo, Junbo Ge, Changsheng Ma, Gregg C Fonarow, Louise Morgan, Jing Liu, Jun Liu, Mengge Zhou, Dong Zhao, Yujie Zhou, Xin Zhou, the CCC-ACS Investigators
doi : 10.1093/eurheartj/ehab418
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3175–3186
Emerging evidence has linked cholesterol metabolism with platelet responsiveness. We sought to examine the dose–response relationship between low-density lipoprotein cholesterol (LDL-C) and major in-hospital bleeds in acute coronary syndrome (ACS) patients.
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Diana A Gorog, Eliano P Navarese, Felicita Andreotti
doi : 10.1093/eurheartj/ehab479
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3187–3189
Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis
Cecilia Becattini, Giorgio Maraziti, David R Vinson, Austin C C Ng, Paul L den Exter, Benoit Côté, Simone Vanni, Rami Doukky, Danai Khemasuwan, Anthony J Weekes, Thiago Horta Soares, Savas Ozsu, Hernan Polo Friz, Serhat Erol, Giancarlo Agnelli, David Jiménez
doi : 10.1093/eurheartj/ehab329
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3190–3199
Patients with acute pulmonary embolism (PE) at low risk for short-term death are candidates for home treatment or short-hospital stay. We aimed at determining whether the assessment of right ventricle dysfunction (RVD) or elevated troponin improves identification of low-risk patients over clinical models alone.
Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data
George Dangas, Johny Nicolas, Roxana Mehran
doi : 10.1093/eurheartj/ehab377
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3203–3204
Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation
Jurriën ten Berg
doi : 10.1093/eurheartj/ehab380
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Pages 3205–3206
COVID-19 vaccine induced prothrombotic immune thrombocytopenia
Cheng Xie, Laura Vincent, Andrew Chadwick, Heiko Peschl
doi : 10.1093/eurheartj/ehab237
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Page 3206
Major left ventricular thrombi in an adolescent with COVID-19-associated inflammatory syndrome
Ond?ej Materna, Karel Koubsk?, Radek P?dr, Jan Janou?ek
doi : 10.1093/eurheartj/ehab165
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Page 3207
Corrigendum to: Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials
doi : 10.1093/eurheartj/ehab265
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Page 3202
Erratum to: Prevention of CV outcomes in antihyperglycemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, atherosclerotic cardiovascular disease: to start or not to start with metformin
doi : 10.1093/eurheartj/ehaa997
European Heart Journal, Volume 42, Issue 33, 1 September 2021, Page 3204
